Global Hereditary Disease Testing Supply, Demand and Key Producers, 2023-2029

Global Hereditary Disease Testing Supply, Demand and Key Producers, 2023-2029

The global Hereditary Disease Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Hereditary Disease Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hereditary Disease Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hereditary Disease Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Hereditary Disease Testing total market, 2018-2029, (USD Million)

Global Hereditary Disease Testing total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Hereditary Disease Testing total market, key domestic companies and share, (USD Million)

Global Hereditary Disease Testing revenue by player and market share 2018-2023, (USD Million)

Global Hereditary Disease Testing total market by Type, CAGR, 2018-2029, (USD Million)

Global Hereditary Disease Testing total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Hereditary Disease Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Myriad Genetics, Invitae, Illumina, Natera, Laboratory Corporation of America Holdings, F. Hoffmann-La Roche, Quest Diagnostics, CooperSurgical and Agilent Technologies, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hereditary Disease Testing market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Hereditary Disease Testing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Hereditary Disease Testing Market, Segmentation by Type
Hereditary Cancer Testing
Hereditary Non-cancer Testing

Global Hereditary Disease Testing Market, Segmentation by Application
Hospital
Clinic
Laboratory
Others

Companies Profiled:
Myriad Genetics
Invitae
Illumina
Natera
Laboratory Corporation of America Holdings
F. Hoffmann-La Roche
Quest Diagnostics
CooperSurgical
Agilent Technologies
Thermo Fisher Scientific
Twist Bioscience
Sophia Genetics
Fulgent Genetic
Medgenome
CENTOGENE

Key Questions Answered

1. How big is the global Hereditary Disease Testing market?

2. What is the demand of the global Hereditary Disease Testing market?

3. What is the year over year growth of the global Hereditary Disease Testing market?

4. What is the total value of the global Hereditary Disease Testing market?

5. Who are the major players in the global Hereditary Disease Testing market?